The Human Reproductive System: What Every Aspiring Embryologist Must Know First

Before you can understand IVF, embryo culture, or sperm preparation — you must understand the biological system those procedures are designed to assist. This guide covers the complete male and female reproductive systems, their anatomy, their physiology, and what each component means for the clinical embryologist at the bench.

Why This Comes Before Everything Else

Many students jump straight to IVF protocols, embryo grading, or cryopreservation without first understanding the biological system those procedures are designed to assist. That approach leads to surface-level knowledge — you can follow a protocol without understanding why each step exists. At GRACE, we believe the best embryologists are those who understand the biology so deeply that the clinical procedures make intuitive sense. This article is that foundation — the anatomy and physiology of the human reproductive system, explained through the lens of what it means at the laboratory bench.

1. The Female Reproductive System

The female reproductive system is one of the most physiologically complex systems in the human body. It is designed to produce oocytes, support fertilisation, and nurture a developing embryo for nine months. For the clinical embryologist, every structure in this system directly influences the procedures performed in the IVF laboratory.

1.1 The Ovaries

The ovaries are paired, almond-shaped organs located on either side of the uterus in the pelvic cavity, each approximately 3–5 cm in length. They are the female gonads — performing two fundamental functions: oogenesis (producing oocytes) and steroidogenesis (producing oestrogen and progesterone).

Structure of the Ovary

The outer cortex contains the follicle population — thousands of primordial follicles embedded in a stromal matrix. This is where all oocyte development occurs. The cortex is where ovarian stimulation drugs act during IVF. In fertility preservation (egg freezing), it is the cortex that is removed, processed, and stored.

The inner medulla contains blood vessels, lymphatics, nerves, and loose connective tissue. It provides the blood supply that delivers FSH and LH to the follicles and carries oestrogen and progesterone from the ovary into the circulation.

The germinal epithelium is a single layer of cuboidal cells covering the ovary's surface. Despite its name, it does NOT produce oocytes — this is a historical misnomer. All oocytes originate from primordial germ cells that migrated to the gonad during fetal development.

The tunica albuginea is a dense fibrous capsule beneath the germinal epithelium. At ovulation, the tunica albuginea and cortex must rupture to release the oocyte — a process actively facilitated by prostaglandins and proteolytic enzymes. This rupture is visualised during egg collection in IVF as a follicle that has already released its egg.

1.2 The Follicle — The Oocyte's Home

The ovarian follicle is the fundamental functional unit of the female reproductive system. Each follicle contains one oocyte surrounded by supporting granulosa cells. The follicle develops through a long developmental sequence — from a microscopic primordial follicle to the pre-ovulatory Graafian follicle that is approximately 20mm in diameter at the time of ovulation.

Why the Antral Follicle Count (AFC) Matters in IVF

When a patient comes to an IVF clinic for an initial assessment, the doctor performs a transvaginal ultrasound on Day 2 or 3 of the menstrual cycle and counts the antral follicles — small fluid-filled follicles between 2–10mm visible in both ovaries combined.

AFC directly reflects the ovarian reserve — the remaining supply of primordial follicles — and predicts the likely response to ovarian stimulation. An AFC above 15 indicates a high ovarian reserve with good stimulation response expected, though with a higher OHSS risk. An AFC between 5 and 15 indicates a normal ovarian reserve, representing a typical IVF candidate. An AFC below 5 indicates a low ovarian reserve, where higher stimulation doses may be needed and fewer eggs are expected.

For an aspiring embryologist, AFC is one of the first numbers you will encounter in every patient's IVF file. Understanding what it means biologically — that each visible antral follicle represents one potentially retrievable oocyte — connects the ultrasound report to the embryology laboratory outcome.

1.3 The Fallopian Tubes (Uterine Tubes)

The two fallopian tubes are muscular, tubular structures approximately 10–14 cm in length, extending from the uterine cornua to the ovaries. Despite their relatively simple appearance, they are among the most functionally sophisticated structures in the reproductive system — and their dysfunction accounts for a significant proportion of cases requiring IVF.

Regions of the Fallopian Tube

The infundibulum is the funnel-shaped distal end with finger-like projections called fimbriae that sweep across the ovarian surface at ovulation. The fimbriae capture the ovulated cumulus-oocyte complex and direct it into the tube. Fimbrial damage from PID or endometriosis is a major cause of infertility — the oocyte cannot be captured. IVF bypasses fimbrial capture entirely by retrieving eggs directly from follicles.

The ampulla is the widest, most convoluted part of the tube — the site of natural fertilisation in vivo. Sperm that have successfully traversed the uterus and uterine junction are stored here in folds of the epithelium before meeting the oocyte. The capacitation process partially occurs here. In IVF, the culture dish replaces the ampullary environment.

The isthmus is the narrower, straighter segment connecting the ampulla to the uterus. It acts as a physiological gate — preventing too many sperm from reaching the ampulla at once. Spermatozoa are temporarily stored in crypts of the isthmic epithelium and released in controlled numbers as ovulation approaches.

The intramural (interstitial) segment is the short segment that passes through the uterine wall. Blockage here or at the uterotubal junction is detected by hysterosalpingography (HSG) — a tubal patency test performed before IVF. Bilateral tubal blockage is one of the primary indications for IVF.

The tubal epithelium is lined with two cell types: ciliated cells, whose coordinated beating propels the oocyte, zygote, and early embryo toward the uterus, and secretory cells that produce tubal fluid — the natural embryo culture medium, rich in amino acids, growth factors, and metabolic substrates. Modern IVF culture media are designed to approximate this tubal fluid composition.

1.4 The Uterus

The uterus is a hollow, pear-shaped muscular organ approximately 7–9 cm in length, positioned in the pelvis between the bladder and rectum. It is the site of embryo implantation and the organ that sustains pregnancy. For IVF, the uterus is the destination of the embryo transfer — and its receptivity at the time of transfer directly determines implantation success.

Layers of the Uterus

The perimetrium is the outermost serosal layer — the peritoneal covering of the uterus. It is not directly relevant to IVF outcomes but is involved in the pain response to uterine procedures and in conditions like peritoneal endometriosis.

The myometrium is the thick middle muscular layer composed of smooth muscle bundles. Its contractility produces menstruation and, during pregnancy, labour contractions. During embryo transfer, myometrial contractions can expel transferred embryos — this is why transfers are often performed gently, and why some clinics time transfers to avoid contraction peaks.

The endometrium is the inner lining and the most critical layer for IVF. It is a dynamic, hormonally responsive tissue that grows, differentiates, and sheds with each menstrual cycle. It is composed of a permanent basal layer that does not shed and regenerates the functional layer each cycle, and a functional layer that proliferates under oestrogen, matures under progesterone, and sheds at menstruation. Embryo implantation occurs only in the functional endometrium — and only during a narrow window of optimal receptivity called the implantation window (Days 20–24 of a 28-day cycle).

Endometrial Assessment in IVF — Why It Matters

Before an embryo transfer, the embryologist and clinician assess the endometrium on ultrasound. A minimum thickness of 7mm is generally required for embryo transfer, with the optimal range being 8–12mm showing a triple-line pattern on ultrasound. Below 6mm is classified as a thin endometrium, associated with very low implantation rates, and transfer may be cancelled.

The triple-line or trilaminar pattern shows three distinct lines visible on ultrasound — outer echogenic borders plus a central echogenic line — indicating adequate oestrogenic stimulation. A homogeneous or hyperechoic appearance is seen in the secretory phase after progesterone support, which is a normal pre-transfer appearance.

The ERA test (Endometrial Receptivity Analysis) uses biopsy and transcriptomic profiling to identify a patient's personalised implantation window — relevant in cases of repeated implantation failure despite good embryos.

For the embryologist, the endometrial assessment is performed by the clinician, but embryologists must understand it because it directly determines whether the embryo transfer proceeds or is cancelled. Good embryos combined with an unreceptive endometrium results in a failed transfer.

1.5 The Cervix and Vagina

The cervix is the narrow, lower part of the uterus that protrudes into the vaginal canal. It produces cervical mucus whose quality changes dramatically across the menstrual cycle under hormonal control. Around ovulation, under oestrogen influence, cervical mucus becomes thin, watery, and spinnbarkeit (stretchable) — specifically designed to facilitate sperm penetration. After ovulation, progesterone makes it thick and impenetrable.

In IVF, the embryo transfer catheter passes through the cervix into the uterine cavity — a procedure that requires knowledge of cervical anatomy, the risk of difficult cannulation in cases of cervical stenosis, and the importance of an atraumatic, non-contaminating transfer technique.

2. The Male Reproductive System

The male reproductive system is anatomically simpler than the female system but is responsible for producing, maturing, and delivering hundreds of millions of spermatozoa per ejaculation — each one a potential fertilising cell. For the clinical embryologist, the male reproductive system is the source of the sperm sample that arrives in the laboratory every IVF morning.

2.1 The Testes

The testes are paired, oval-shaped organs located outside the abdominal cavity in the scrotal sac. This external positioning is physiologically essential — spermatogenesis requires a temperature approximately 2–3°C below core body temperature (34–35°C vs. 37°C). Cryptorchidism (undescended testes) directly impairs spermatogenesis by elevating testicular temperature, often producing irreversible damage if not corrected before puberty.

Structure of the Testis

The seminiferous tubules are the primary functional unit of the testis. Approximately 250–300 metres of coiled tubules are packed within each testis. These tubules contain the developing sperm cells at various stages, from spermatogonia through to spermatozoa. The entire spermatogenesis process takes approximately 74 days in humans — this is clinically important because lifestyle or medical interventions affecting spermatogenesis take approximately 3 months to show improvement in semen analysis.

Sertoli cells are large nursing cells lining the seminiferous tubules. They form the blood-testis barrier, provide structural support and nutrients to developing sperm, secrete inhibin B (which provides negative feedback on FSH), secrete androgen-binding protein (ABP) to concentrate testosterone locally, and phagocytose excess cytoplasm shed during spermiation. Sertoli cell number is the primary determinant of sperm production capacity — fixed early in life. Sertoli cell dysfunction is a key mechanism in non-obstructive azoospermia.

Leydig cells are interstitial cells located in the connective tissue between seminiferous tubules. They respond to LH by synthesising and secreting testosterone — the primary male sex hormone. Testosterone is essential for spermatogenesis locally and for the development of secondary sexual characteristics systemically. In hypogonadotropic hypogonadism (low LH/FSH from pituitary dysfunction), both testosterone production and spermatogenesis fail — but can often be rescued with gonadotrophin therapy.

The blood-testis barrier (BTB) is formed by tight junctions between adjacent Sertoli cells. It divides the seminiferous tubule into a basal compartment containing spermatogonia and an adluminal compartment containing developing spermatocytes and spermatids. The BTB protects developing sperm from the immune system — sperm antigens appear after immunological tolerance is established in infancy, so they would be recognised as foreign without the BTB. Disruption of the BTB by infection, orchitis, or trauma can trigger anti-sperm antibodies and autoimmune infertility.

2.2 Spermatogenesis — How Sperm Are Made

Spermatogenesis is the process by which diploid spermatogonial stem cells are transformed into haploid, motile spermatozoa. It occurs continuously from puberty to old age, unlike oogenesis which is finite from birth. The complete process takes approximately 74 days in humans.

In Phase 1, mitotic amplification occurs: spermatogonia (type A) divide mitotically to maintain the stem cell pool and produce type B spermatogonia that will enter meiosis. In Phase 2, meiosis I takes place: primary spermatocytes (diploid, 46 chromosomes) undergo meiosis I — homologous chromosome separation — producing secondary spermatocytes (haploid, 23 chromosomes, but each chromosome still has 2 sister chromatids). In Phase 3, meiosis II takes place: a rapid second meiotic division separates sister chromatids, producing 4 haploid spermatids (23 chromosomes, single chromatid each) from each primary spermatocyte. In Phase 4, spermiogenesis occurs: the spermatids undergo dramatic morphological transformation — condensing the nucleus, forming the acrosome from the Golgi apparatus, assembling the flagellum from centrioles, and shedding excess cytoplasm as the residual body. This produces the fully formed spermatozoon.

Spermatogenesis Timing and the IVF Laboratory

The 74-day spermatogenesis cycle has direct clinical implications. When a patient is advised to stop smoking, reduce alcohol, address a varicocele, or start antioxidant therapy, the earliest any improvement will be visible in a semen analysis is 3 months. A febrile illness above 38.5°C can temporarily impair spermatogenesis — a semen analysis done 4–6 weeks after a fever episode may show significantly reduced sperm count and motility, and waiting 3 months before repeating the test gives a more representative result. Chemotherapy and radiation can permanently destroy spermatogonial stem cells, making sperm banking before cancer treatment strongly recommended.

For the embryologist, when a semen sample arrives in the laboratory, it is the product of a spermatogenic cycle that began 74 days earlier. The quality you see reflects the man's health over the past 2.5 months.

2.3 The Epididymis — Where Sperm Mature

The epididymis is a highly coiled tube approximately 6 metres in length when uncoiled, running along the posterior surface of each testis. Sperm spend 2–12 days transiting the epididymis — a period during which they undergo profound functional maturation that renders them capable of fertilisation.

Sperm leaving the testes are immotile and incapable of fertilising an oocyte. As they travel through the epididymis from head to body to tail, the epididymal epithelium modifies the sperm surface — adding and removing proteins, altering the lipid composition of the plasma membrane, and exposing surface receptors that will later mediate zona binding. The epididymis also adds decapacitation factors — proteins that prevent premature capacitation until the sperm reach the female reproductive tract.

In men with obstructive azoospermia (blocked ducts but normal spermatogenesis), sperm can be retrieved surgically from the epididymis by PESA (Percutaneous Epididymal Sperm Aspiration) or MESA (Microsurgical Epididymal Sperm Aspiration). These epididymal sperm are mature enough for ICSI — but typically cannot fertilise naturally or via standard IVF because they require the zona penetration that ICSI bypasses.

2.4 The Vas Deferens and Seminal Vesicles

The vas deferens is the muscular duct that transports sperm from the epididymal tail to the ejaculatory duct at the time of ejaculation. It is the structure cut in a vasectomy or obstructed in certain male infertility conditions. In men with congenital bilateral absence of the vas deferens (CBAVD) — strongly associated with CFTR mutations (the cystic fibrosis gene) — sperm must be retrieved surgically by PESA or MESA for ICSI.

The seminal vesicles produce approximately 70% of the ejaculate volume — a fructose-rich fluid that provides energy for sperm motility, plus coagulating proteins that initially cause the semen to clot post-ejaculation, then dissolve within minutes under prostate-derived liquefaction enzymes. The prostate gland contributes 20–30% of ejaculate volume, producing the PSA enzyme and zinc-rich alkaline fluid that neutralises the acidic vaginal environment.

Semen Volume, Seminal Vesicles, and the IVF Lab

When a semen sample arrives in the IVF laboratory, the embryologist's first observation is its volume — normal being above 1.4 mL per WHO 2021 criteria. Low volume can indicate ejaculatory duct obstruction, retrograde ejaculation where semen enters the bladder, absent or underdeveloped seminal vesicles associated with CFTR mutations, or a technical collection error. The liquefaction time — how long the ejaculate takes to change from gel to liquid, normally within 15–60 minutes — is also assessed. Abnormal liquefaction affects sperm motility analysis accuracy and may indicate prostate dysfunction.

2.5 The Path of the Sperm — From Testis to Oocyte

A spermatogonium in the seminiferous tubule of the testis undergoes spermatogenesis over 74 days. Newly formed spermatozoa — initially immotile — are released into the seminiferous tubule lumen and carried to the rete testis. They then transit through the epididymis over 2–12 days, during which they acquire motility potential and surface modifications, and are stored in the epididymal tail until ejaculation is triggered.

At ejaculation, smooth muscle contraction propels sperm through the vas deferens, ejaculatory duct, and urethra, as accessory gland secretions mix en route. Semen is deposited in the vagina, where most sperm are destroyed by vaginal acidity. Cervical mucus, if mid-cycle, allows a small fraction through. Selected sperm swim through the uterine cavity and enter the fallopian tube, where they are stored in the isthmic crypts. At ovulation, stored sperm are released, and during transit through the ampulla, capacitation is completed. One capacitated sperm penetrates the cumulus, binds ZP3 on the zona pellucida, undergoes the acrosomal reaction, and penetrates the zona to fuse with the oocyte. Fertilisation occurs, forming a zygote in the ampulla of the fallopian tube.

3. Hormonal Control of the Reproductive System

Both the male and female reproductive systems are regulated by the same fundamental hormonal axis: the Hypothalamic-Pituitary-Gonadal (HPG) Axis. Understanding this axis is essential because all IVF ovarian stimulation protocols work by overriding or manipulating it.

3.1 The HPG Axis

The hypothalamus releases GnRH (Gonadotropin-Releasing Hormone) in pulses every 60–90 minutes. Pulsatile release is essential — continuous GnRH actually suppresses the axis, and this is exploited by GnRH agonist drugs used in IVF protocols. The hypothalamus integrates signals from body weight, stress (cortisol), sleep, and energy balance — explaining why extreme weight loss, over-exercise, or chronic stress can disrupt menstrual cycles.

The anterior pituitary gland responds to GnRH pulses by releasing FSH (Follicle Stimulating Hormone) and LH (Luteinising Hormone). FSH drives follicle development and oestrogen production. LH triggers ovulation (the LH surge) and drives testosterone production in the male. In IVF, injectable FSH and LH medications such as Gonal-F, Menopur, and Fostimon directly replace or supplement the pituitary signal.

The gonads (ovaries and testes) respond to FSH and LH. In women, growing follicles produce oestradiol — its positive feedback at mid-cycle triggers the LH surge, while its negative feedback at other times suppresses FSH and LH. After ovulation, the corpus luteum produces progesterone. In men, FSH drives spermatogenesis via Sertoli cells, and LH drives testosterone production via Leydig cells. Testosterone and oestradiol feed back to the hypothalamus and pituitary to regulate GnRH and gonadotrophin release.

3.2 Key Reproductive Hormones and Their Clinical Roles

GnRH is produced by the hypothalamus and stimulates pituitary FSH and LH release in both males and females. In IVF, GnRH agonists are used in long protocols and GnRH antagonists in short protocols to prevent premature LH surge.

FSH is produced by the anterior pituitary and stimulates follicle growth and oestrogen production in females, and spermatogenesis via Sertoli cells in males. Injectable FSH such as Gonal-F and Fostimon is used to stimulate multiple follicle development in IVF.

LH is produced by the anterior pituitary. Its surge triggers ovulation in females, and it drives testosterone production via Leydig cells in males. Injectable LH or hCG is used as a trigger shot to mimic the LH surge and initiate final oocyte maturation.

Oestradiol (E2) is produced by the granulosa cells of the ovary. It thickens the endometrium, triggers cervical mucus changes, and at mid-cycle its positive feedback triggers the LH surge. Serum E2 is monitored during stimulation to assess follicle activity, and excessive E2 increases OHSS risk.

Progesterone is produced by the corpus luteum after ovulation and by the placenta during pregnancy. It prepares the endometrium for implantation and maintains pregnancy. Vaginal or intramuscular progesterone is prescribed after egg collection as luteal support to maintain the endometrium for implantation.

AMH (Anti-Müllerian Hormone) is produced by granulosa cells of small antral follicles. It reflects ovarian reserve and inhibits premature follicle recruitment. It is measured before IVF to predict ovarian response and guide stimulation dose selection.

Inhibin B is produced by granulosa cells and provides negative feedback on FSH, acting as a marker of follicle number. In men it is produced by Sertoli cells and serves as a marker of spermatogenic function.

Testosterone is produced by Leydig cells in response to LH and is the primary male sex hormone, essential for spermatogenesis and secondary sexual characteristics. Low testosterone (hypogonadism) in men causes poor spermatogenesis and is responsive to hCG therapy.

hCG is produced by the placenta in pregnancy and is injected in IVF. It maintains the corpus luteum in early pregnancy and is used as the trigger shot — administered 34–36 hours before egg retrieval — to mimic the LH surge.

3.3 The Female Menstrual Cycle — A Month-by-Month Story

The menstrual cycle is the result of precisely coordinated hormonal events that govern follicle development, ovulation, and endometrial preparation. Understanding it cycle-by-cycle is essential for IVF timing, embryo transfer planning, and monitoring patients on stimulation.

Days 1–5 — Menstruation

Progesterone from the previous cycle's corpus luteum falls, causing the endometrial functional layer to shed. FSH begins to rise as it is released from pituitary negative feedback, and a new cohort of antral follicles is recruited. For IVF, Day 2–3 is when baseline ultrasound and blood tests are performed before starting stimulation injections.

Days 5–13 — Follicular / Proliferative Phase

Rising FSH stimulates 5–15 antral follicles to grow. Granulosa cells produce increasing oestradiol. One follicle becomes dominant — the largest, with the most FSH receptors — and grows preferentially. Oestradiol thickens the endometrium in the proliferative phase, and cervical mucus becomes thin and watery. For IVF, monitoring ultrasounds and blood tests track follicle size and E2 levels, and the dominant follicle should reach 17–22mm before the trigger.

Day 14 — Ovulation (LH Surge)

Peak oestradiol triggers a sudden, massive surge of LH from the pituitary. The LH surge triggers final oocyte maturation (MII completion, first polar body extrusion), follicle wall rupture, and cumulus-oocyte complex release. The oocyte is captured by the fimbriae and enters the fallopian tube. For IVF, the trigger shot (hCG or GnRH agonist) mimics this surge, and egg collection is timed 34–36 hours after trigger.

Days 15–28 — Luteal / Secretory Phase

The ruptured follicle becomes the corpus luteum, secreting progesterone. Progesterone transforms the endometrium into a secretory state with glandular development and glycogen production — the receptive implantation window opens on Days 20–24. If fertilisation occurs, hCG from the trophoblast rescues the corpus luteum. If no fertilisation occurs, the corpus luteum degenerates, progesterone falls, and menstruation begins. For IVF, luteal support (vaginal progesterone) is given to maintain the endometrium.

4. The Clinical Bridge — From Anatomy to the IVF Laboratory

Now that you understand the anatomy and physiology of the reproductive system, we can connect each biological structure directly to the clinical procedures you will encounter — and eventually perform — as a clinical embryologist.

A diminished ovarian reserve — too few follicles remaining to respond to stimulation, or premature ovarian insufficiency — is addressed through higher FSH doses, mild stimulation protocols, egg donation IVF, or fertility preservation before ovarian damage occurs.

Poor ovarian response where few follicles grow despite stimulation, or PCOS where too many follicles grow creating an OHSS risk, is managed through dose adjustment, different protocols (antagonist vs agonist), coasting, or a freeze-all strategy.

Anovulation due to PCOS or hypothalamic amenorrhoea, or a premature LH surge in stimulated cycles, is addressed through ovulation induction using letrozole or clomiphene, GnRH antagonists to prevent premature surges, or a trigger shot to induce ovulation.

Bilateral tubal blockage or hydrosalpinx is addressed by IVF, which completely bypasses the tubes. Hydrosalpinx — a fluid-filled tube that is embryotoxic to the endometrium — is surgically removed before IVF.

Non-obstructive azoospermia where no sperm are found in the ejaculate is addressed by testicular sperm extraction (TESE/microTESE), while oligozoospermia is addressed with ICSI.

Obstructive azoospermia where sperm are produced but cannot exit, or CBAVD with absent vas deferens, is managed with PESA, MESA, or TESE to retrieve sperm surgically, followed by ICSI for fertilisation.

Uterine implantation issues such as a thin endometrium, fibroids, polyps, Asherman's syndrome, or poor receptivity are addressed through oestrogen preparation, hysteroscopic surgery to remove polyps, fibroids, or adhesions, the ERA test, or donor embryo.

Hypogonadotropic hypogonadism with low FSH and LH causing no follicle stimulation is treated with injectable FSH plus LH therapy, or pulsatile GnRH pump therapy to restore the natural axis.

Fertilisation failure in standard IVF where sperm cannot penetrate the zona or acrosomal defects are present is addressed by ICSI, which bypasses zona binding and the acrosomal reaction entirely. Oocyte activation failure is addressed with AOA (assisted oocyte activation).

5. Test Yourself — Questions for Aspiring Embryologists

Why does spermatogenesis require a temperature lower than core body temperature — and what clinical condition results when this fails?

Spermatogenesis requires a temperature of approximately 34–35°C — about 2–3°C below the core body temperature of 37°C. This requirement is met by the external location of the testes in the scrotal sac, which positions them away from core body heat. The scrotum also has specialised thermoregulatory mechanisms: the pampiniform plexus, a network of veins that cools arterial blood entering the testis via a countercurrent heat exchange mechanism, and the cremaster muscle, which raises and lowers the testes to regulate their temperature.

In cryptorchidism (undescended testes), one or both testes fail to descend into the scrotum during development, remaining in the inguinal canal or abdomen where they are exposed to core body temperature. This impairs spermatogenesis, leading to reduced sperm production and, if bilateral and uncorrected, infertility. Cryptorchidism is also a risk factor for testicular malignancy. Clinical management involves orchidopexy — surgical descent of the testis into the scrotum — recommended before age 2.

In varicocele, dilation of the pampiniform plexus veins impairs the cooling mechanism, raising intratesticular temperature. It is the most common correctable cause of male infertility. Varicocele repair can improve semen parameters in many men — but the improvement takes approximately 3 months (one spermatogenic cycle) to become visible in a semen analysis.

What is the clinical significance of the fallopian tube's ampullary region — and what happens if it is diseased?

The ampulla of the fallopian tube is the site of natural fertilisation in vivo — where the capacitated spermatozoon meets the cumulus-oocyte complex and fertilisation occurs. The ampullary environment provides the natural culture medium for fertilisation: tubal fluid rich in amino acids, energy substrates, and growth factors secreted by the tubal epithelial cells.

Disease of the ampulla most commonly results from pelvic inflammatory disease (PID), endometriosis, or previous ectopic pregnancy. Consequences include peritubal adhesions where the tube becomes kinked and blocked, hydrosalpinx where the tube fills with fluid blocking at both ends, and loss of the specialised ciliated epithelium impairing oocyte transport even without complete blockage.

Bilateral tubal blockage is a primary indication for IVF — the procedure completely bypasses the tubes. A hydrosalpinx is associated with significantly reduced IVF implantation and pregnancy rates, as the leakage of toxic tubal fluid into the uterine cavity is embryotoxic. The standard recommendation before IVF is surgical removal (salpingectomy) or ligation of the hydrosalpinx. An ectopic pregnancy — implantation within the fallopian tube rather than the uterus — is a life-threatening emergency requiring urgent surgery. IVF does not completely eliminate ectopic risk, as embryos transferred to the uterus can migrate to the tube.

What is the LH surge, and why do IVF clinics monitor for it so carefully during ovarian stimulation?

The LH surge is a sudden, dramatic rise in Luteinising Hormone secretion from the anterior pituitary gland, triggered by the peak oestradiol levels from the dominant pre-ovulatory follicle. It occurs approximately 36–40 hours before ovulation in a natural cycle. The LH surge triggers final nuclear maturation of the oocyte (completion of meiosis I, extrusion of the first polar body, arrest at Metaphase II), follicle wall rupture and ovulation, and formation of the corpus luteum.

In an IVF stimulation cycle, the patient receives injectable FSH to grow multiple follicles simultaneously. As multiple follicles grow and produce oestradiol together, oestradiol levels rise much higher and faster than in a natural cycle. This high oestradiol can trigger a premature LH surge — ovulation occurring before the embryologist can retrieve the eggs, losing the entire cycle's work.

To prevent premature LH surge, IVF protocols use GnRH antagonists such as Cetrotide or Orgalutran, which are added mid-stimulation to block LH receptors on the pituitary and suppress LH. Alternatively, GnRH agonist down-regulation (the long protocol, using Lupron or Decapeptyl) is started before stimulation to initially flood then permanently deplete pituitary GnRH receptors, suppressing the axis entirely before FSH injections begin.

When follicles reach the target size of 17–22mm, an hCG trigger shot (Ovitrelle) or GnRH agonist trigger is administered — this mimics the natural LH surge, triggering final maturation. Egg collection is then precisely timed 34–36 hours later, before the follicles rupture spontaneously.

6. Key Terms — Reproductive System Glossary

Gonads are the primary reproductive organs — ovaries in females, testes in males — that produce gametes and sex hormones.

A follicle is the functional unit of the ovary, containing one developing oocyte surrounded by granulosa and theca cells.

Granulosa cells are the inner follicle cells that produce oestrogen under FSH stimulation and become luteal cells post-ovulation.

Theca cells are the outer follicle cells that produce androgens under LH stimulation. These androgens are then converted to oestrogen by granulosa cells.

The corpus luteum is the post-ovulatory structure formed from the ruptured follicle. It produces progesterone for 14 days if no pregnancy occurs.

AMH (Anti-Müllerian Hormone) is produced by granulosa cells of small antral follicles and serves as a marker of ovarian reserve.

AFC (Antral Follicle Count) is the number of 2–10mm follicles visible on Day 2–3 ultrasound, and it predicts ovarian stimulation response.

FSH (Follicle Stimulating Hormone) is released from the anterior pituitary. It drives follicle growth in females and spermatogenesis in males.

LH (Luteinising Hormone) is released from the anterior pituitary. Its surge triggers ovulation and it drives testosterone production in males.

The HPG Axis (Hypothalamic-Pituitary-Gonadal Axis) is the master hormonal control system of reproduction.

GnRH (Gonadotropin-Releasing Hormone) is released in pulses from the hypothalamus and stimulates FSH and LH release.

Oestradiol (E2) is the primary female sex hormone produced by granulosa cells. It thickens the endometrium, drives cervical mucus changes, and triggers the LH surge at mid-cycle.

Progesterone is produced by the corpus luteum after ovulation. It prepares the endometrium for implantation and supports early pregnancy.

The endometrium is the inner lining of the uterus and the site of embryo implantation. It undergoes cyclical changes throughout the menstrual cycle.

The implantation window refers to Days 20–24 of a 28-day cycle — the narrow period when the endometrium is maximally receptive to embryo implantation.

Spermatogenesis is the process of producing spermatozoa from spermatogonial stem cells in the seminiferous tubules, taking approximately 74 days.

Sertoli cells are nursing cells in the seminiferous tubules that support developing sperm, form the blood-testis barrier, and secrete inhibin B.

Leydig cells are interstitial testicular cells that produce testosterone in response to LH stimulation.

The epididymis is the coiled duct where sperm mature and acquire motility potential during a transit of 2–12 days.

Capacitation is the functional transformation of sperm during transit through the female reproductive tract or IVF media that enables fertilisation.

The ampulla is the widest segment of the fallopian tube and the site of natural fertilisation in vivo.

Cryptorchidism is the failure of one or both testes to descend into the scrotum, which impairs spermatogenesis due to elevated temperature.

Azoospermia is the complete absence of sperm in the ejaculate, which can be either obstructive (due to blockage) or non-obstructive (due to spermatogenic failure).

PESA and MESA (Percutaneous and Microsurgical Epididymal Sperm Aspiration) are procedures for retrieving sperm from the epididymis.

TESE and microTESE (Testicular Sperm Extraction) are surgical procedures for retrieving sperm from testicular tissue when no sperm reach the epididymis.

Hydrosalpinx is a fluid-filled, blocked fallopian tube that is embryotoxic and must be removed before IVF, as it significantly reduces success rates.

Ovulation induction is the medical stimulation of ovulation using drugs such as letrozole, clomiphene, or FSH in anovulatory patients.

The trigger shot is an injection of hCG or GnRH agonist that mimics the LH surge and is administered 34–36 hours before egg collection in IVF.

7. High-Yield Revision Points

Female System

The ovaries are paired gonads that produce oocytes through oogenesis and produce hormones through steroidogenesis. The follicle is the functional unit of the ovary, with one oocyte per follicle. The antral follicle count (AFC) on Day 2–3 ultrasound is the best clinical marker of ovarian reserve. The fallopian tube ampulla is the site of natural fertilisation in vivo. Hydrosalpinx is a blocked, fluid-filled tube that is embryotoxic and must be surgically removed before IVF. The endometrium must be at least 7mm and trilaminar for embryo transfer. The implantation window falls on Days 20–24 of a 28-day cycle and is progesterone-dependent.

Male System

The testes require a temperature of 34–35°C — 2–3°C below core body temperature — for spermatogenesis. Spermatogenesis takes 74 days, meaning improvements in sperm quality take 3 months to appear. Sertoli cells are the nursing cells of the seminiferous tubules that form the blood-testis barrier and secrete inhibin B. Leydig cells produce testosterone in response to LH. The epididymis is the site of sperm maturation and acquisition of motility over a 2–12 day transit. The seminal vesicles produce approximately 70% of ejaculate volume, providing fructose-rich energy for sperm.

Hormonal Control

The HPG Axis runs from the hypothalamus (GnRH) to the pituitary (FSH and LH) to the gonads (oestrogen, progesterone, and testosterone). FSH drives follicle growth in females and spermatogenesis in males. The LH surge triggers ovulation and occurs 36–40 hours before follicle rupture. GnRH antagonists (Cetrotide) prevent premature LH surge in IVF stimulation cycles. The hCG trigger shot mimics the LH surge, and egg retrieval is timed 34–36 hours later. The corpus luteum produces progesterone after ovulation and is maintained by hCG in early pregnancy. AMH reflects ovarian reserve and is not cycle-dependent — it can be measured on any day.

Clinical Connections

Bilateral tubal blockage is a primary IVF indication, as IVF bypasses the tubes completely. Obstructive azoospermia is managed with PESA or MESA, while non-obstructive azoospermia requires TESE or microTESE plus ICSI. CBAVD (absent vas deferens) is associated with CFTR (cystic fibrosis) gene mutations. Cryptorchidism leads to impaired spermatogenesis and increased testicular cancer risk, and is managed with orchidopexy by age 2. IVF completely bypasses the fallopian tubes, cervical mucus barrier, and natural gamete transport.

Conclusion

The human reproductive system is not just background biology — it is the clinical context within which every embryology procedure exists. The ovary's follicle pool determines how many eggs an IVF cycle can produce. The fallopian tube's ampulla is the natural fertilisation chamber that IVF replicates in a culture dish. The endometrium's cyclical transformation under oestrogen and progesterone is what the embryologist must ensure is in sync with the embryo's developmental stage on transfer day. The testis's intricate temperature-regulated machinery produces the sperm that arrives in the laboratory every morning.

When you understand why each structure exists and how it functions, the clinical procedures built around it become logical rather than arbitrary — and you become the kind of embryologist who understands, not just follows, the protocol.

Disclaimer

This blog is for educational purposes. Content is developed for aspiring embryology students and reviewed by faculty at GRACE Embryology Institution.